We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.08B
AUM Growth
+$243M
Cap. Flow
+$209M
Cap. Flow %
19.31%
Top 10 Hldgs %
37.4%
Holding
354
New
57
Increased
163
Reduced
56
Closed
39

Sector Composition

Rank Sector Weight
1 Technology 8.12%
2 Healthcare 7.11%
3 Financials 5.17%
4 Industrials 4.57%
5 Communication Services 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
151
3M
MMM
$89.1B
$1.21M 0.11%
8,190
+216
+3% +$32.2K
GE icon
152
GE Aerospace
GE
$354B
$1.18M 0.11%
8,295
+939
+13% +$140K
GWRE icon
153
Guidewire Software
GWRE
$11.9B
$1.13M 0.1%
18,749
HUM icon
154
Humana
HUM
$47.8B
$1.12M 0.1%
6,330
-18
-0.3% -$3.12K
SRLN icon
155
State Street Blackstone Senior Loan ETF
SRLN
$5.32B
$1.11M 0.1%
23,495
-310
-1% -$14.6K
DISH
156
DELISTED
DISH Network Corp.
DISH
$1.07M 0.1%
19,588
+139
+0.7% +$7.2K
SDY icon
157
State Street SPDR S&P Dividend ETF
SDY
$21.6B
$1.07M 0.1%
12,711
+1,470
+13% +$125K
AXP icon
158
American Express
AXP
$240B
$1.07M 0.1%
16,693
-1,210
-7% -$77.7K
AGEN
159
Agenus
AGEN
$232M
$1.06M 0.1%
7,541
-3,311
-31% -$380K
BMY icon
160
Bristol-Myers Squibb
BMY
$124B
$1.06M 0.1%
19,588
-446
-2% -$28.6K
SCHF icon
161
Schwab International Equity ETF
SCHF
$66.3B
$1.05M 0.1%
72,834
+20,324
+39% +$287K
NBSE
162
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1.03M 0.1%
913
STML
163
DELISTED
Stemline Therapeutics, Inc.
STML
$1.03M 0.09%
94,785
IMMU
164
DELISTED
Immunomedics Inc
IMMU
$1.02M 0.09%
315,000
DVY icon
165
iShares Select Dividend ETF
DVY
$23.7B
$1.01M 0.09%
11,841
+352
+3% +$30.4K
IWM icon
166
iShares Russell 2000 ETF
IWM
$82.4B
$1.01M 0.09%
8,102
+809
+11% +$98.3K
BVN icon
167
Compañía de Minas Buenaventura
BVN
$7.94B
$972K 0.09%
70,200
BRK.B icon
168
Berkshire Hathaway Class B
BRK.B
$1.06T
$951K 0.09%
6,585
+108
+2% +$15.8K
HDV
169
iShares Core High Dividend ETF
HDV
$14.2B
$937K 0.09%
57,675
TRV icon
170
Travelers Companies
TRV
$81.3B
$896K 0.08%
7,826
+506
+7% +$59.2K
NWN icon
171
Northwest Natural Holdings
NWN
$2.14B
$880K 0.08%
+14,634
New +$915K
INFY icon
172
Infosys
INFY
$45.2B
$879K 0.08%
111,368
-40,000
-26% -$330K
SCHH icon
173
Schwab US REIT ETF
SCHH
$11.6B
$868K 0.08%
40,680
+1,050
+3% +$23K
MCD icon
174
McDonald's
MCD
$188B
$851K 0.08%
7,375
+800
+12% +$94.8K
PEP icon
175
PepsiCo
PEP
$184B
$838K 0.08%
7,701
-207
-3% -$22.3K

Similar funds

Bailard's Q3 2016 Portfolio in Review

As of Q3 2016, Bailard held 354 positions worth $1.08B, up 29% from $840M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bailard deployed $209M of net new capital in Q3 2016, opening 57 new positions and adding to 163 existing holdings. Its largest new stake was Crown Holdings: 58,190 shares worth $3.32M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $53.8M trimmed.

  • Bailard's largest Q3 2016 buy was Crown Holdings: 58,190 shares worth $3.32M.
  • Bailard added most to iShares MSCI Emerging Markets ETF in Q3 2016, an estimated $55.1M increase.
  • Bailard's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $53.8M.
  • Bailard fully exited Vanguard Total Bond Market in Q3 2016, selling an estimated $53.3M.
  • Bailard's ten largest holdings make up 37% of its $1.08B portfolio in Q3 2016.
  • Bailard opened 57 new positions and closed 39 in Q3 2016.
  • Bailard's portfolio value rose 29% quarter-over-quarter to $1.08B.

Based on Bailard's 13F filing for Q3 2016, filed 9 Nov 2016.